InspireMD Q3 2025 Earnings Preview
Source: SeekingAlpha
2025-11-03 11:02:43 ET
More on InspireMD
- InspireMD, Inc. 2025 Q2 - Results - Earnings Call Presentation
- InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript
- InspireMD signals robust U.S. CGuard Prime launch progress and expands clinical pipeline following $58M capital infusion
- Seeking Alpha’s Quant Rating on InspireMD
- Historical earnings data for InspireMD
Read the full article on Seeking Alpha
For further details see:
InspireMD Q3 2025 Earnings Preview
InspireMD Inc.
NASDAQ: NSPR
NSPR Trading
2.81% G/L:
$1.645 Last:
3,701 Volume:
$1.63 Open:
NSPR Latest News
January 12, 2026 09:00:00 am
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
November 24, 2025 07:30:00 am
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
November 19, 2025 04:41:45 pm
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
NSPR Stock Data
$71,856,970
27,939,434
11.21%
23
N/A
Medical Equipment & Supplies
Healthcare
IL
Miami
